‘It’s Not About Me’ – AstraZeneca’s Soriot Says His Pay Rise Will Help European Pharma
AstraZeneca’s CEO says his potential 11% pay rise is needed to help the European industry remain competitive with its higher paying US counterparts.
AstraZeneca’s CEO says his potential 11% pay rise is needed to help the European industry remain competitive with its higher paying US counterparts.